BACKGROUND: Genome-wide association studies (GWAS) for Parkinson's disease have linked two loci (MAPT and SNCA) to risk of Parkinson's disease. We aimed to identify novel risk loci for Parkinson's disease. METHODS: We did a meta-analysis of datasets from five Parkinson's disease GWAS from the USA and Europe to identify loci associated with Parkinson's disease (discovery phase). We then did replication analyses of significantly associated loci in an independent sample series. Estimates of population-attributable risk were calculated from estimates from the discovery and replication phases combined, and risk-profile estimates for loci identified in the discovery phase were calculated. FINDINGS: The discovery phase consisted of 5333 case and 12 019 control samples, with genotyped and imputed data at 7 689 524 SNPs. The replication phase consisted of 7053 case and 9007 control samples. We identified 11 loci that surpassed the threshold for genome-wide significance (p<5×10(-8)). Six were previously identified loci (MAPT, SNCA, HLA-DRB5, BST1, GAK and LRRK2) and five were newly identified loci (ACMSD, STK39, MCCC1/LAMP3, SYT11, and CCDC62/HIP1R). The combined population-attributable risk was 60·3% (95% CI 43·7-69·3). In the risk-profile analysis, the odds ratio in the highest quintile of disease risk was 2·51 (95% CI 2·23-2·83) compared with 1·00 in the lowest quintile of disease risk. INTERPRETATION: These data provide an insight into the genetics of Parkinson's disease and the molecular cause of the disease and could provide future targets for therapies. FUNDING: Wellcome Trust, National Institute on Aging, and US Department of Defense.
BACKGROUND: Genome-wide association studies (GWAS) for Parkinson's disease have linked two loci (MAPT and SNCA) to risk of Parkinson's disease. We aimed to identify novel risk loci for Parkinson's disease. METHODS: We did a meta-analysis of datasets from five Parkinson's disease GWAS from the USA and Europe to identify loci associated with Parkinson's disease (discovery phase). We then did replication analyses of significantly associated loci in an independent sample series. Estimates of population-attributable risk were calculated from estimates from the discovery and replication phases combined, and risk-profile estimates for loci identified in the discovery phase were calculated. FINDINGS: The discovery phase consisted of 5333 case and 12 019 control samples, with genotyped and imputed data at 7 689 524 SNPs. The replication phase consisted of 7053 case and 9007 control samples. We identified 11 loci that surpassed the threshold for genome-wide significance (p<5×10(-8)). Six were previously identified loci (MAPT, SNCA, HLA-DRB5, BST1, GAK and LRRK2) and five were newly identified loci (ACMSD, STK39, MCCC1/LAMP3, SYT11, and CCDC62/HIP1R). The combined population-attributable risk was 60·3% (95% CI 43·7-69·3). In the risk-profile analysis, the odds ratio in the highest quintile of disease risk was 2·51 (95% CI 2·23-2·83) compared with 1·00 in the lowest quintile of disease risk. INTERPRETATION: These data provide an insight into the genetics of Parkinson's disease and the molecular cause of the disease and could provide future targets for therapies. FUNDING: Wellcome Trust, National Institute on Aging, and US Department of Defense.
Authors: Pedro Cano; William Klitz; Steven J Mack; Martin Maiers; Steven G E Marsh; Harriet Noreen; Elaine F Reed; David Senitzer; Michelle Setterholm; Anajane Smith; Marcelo Fernández-Viña Journal: Hum Immunol Date: 2007-02-15 Impact factor: 2.850
Authors: Mohamad Saad; Suzanne Lesage; Aude Saint-Pierre; Jean-Christophe Corvol; Diana Zelenika; Jean-Charles Lambert; Marie Vidailhet; George D Mellick; Ebba Lohmann; Franck Durif; Pierre Pollak; Philippe Damier; François Tison; Peter A Silburn; Christophe Tzourio; Sylvie Forlani; Marie-Anne Loriot; Maurice Giroud; Catherine Helmer; Florence Portet; Philippe Amouyel; Mark Lathrop; Alexis Elbaz; Alexandra Durr; Maria Martinez; Alexis Brice Journal: Hum Mol Genet Date: 2010-11-17 Impact factor: 6.150
Authors: Ying Wang; Jeffrey R O'Connell; Patrick F McArdle; James B Wade; Sarah E Dorff; Sanjiv J Shah; Xiaolian Shi; Lin Pan; Evadnie Rampersaud; Haiqing Shen; James D Kim; Arohan R Subramanya; Nanette I Steinle; Afshin Parsa; Carole C Ober; Paul A Welling; Aravinda Chakravarti; Alan B Weder; Richard S Cooper; Braxton D Mitchell; Alan R Shuldiner; Yen-Pei C Chang Journal: Proc Natl Acad Sci U S A Date: 2008-12-29 Impact factor: 11.205
Authors: Hon-Chung Fung; Sonja Scholz; Mar Matarin; Javier Simón-Sánchez; Dena Hernandez; Angela Britton; J Raphael Gibbs; Carl Langefeld; Matt L Stiegert; Jennifer Schymick; Michael S Okun; Ronald J Mandel; Hubert H Fernandez; Kelly D Foote; Ramón L Rodríguez; Elizabeth Peckham; Fabienne Wavrant De Vrieze; Katrina Gwinn-Hardy; John A Hardy; Andrew Singleton Journal: Lancet Neurol Date: 2006-11 Impact factor: 44.182
Authors: Chris C A Spencer; Vincent Plagnol; Amy Strange; Michelle Gardner; Coro Paisan-Ruiz; Gavin Band; Roger A Barker; Celine Bellenguez; Kailash Bhatia; Hannah Blackburn; Jennie M Blackwell; Elvira Bramon; Martin A Brown; Matthew A Brown; David Burn; Juan-Pablo Casas; Patrick F Chinnery; Carl E Clarke; Aiden Corvin; Nicholas Craddock; Panos Deloukas; Sarah Edkins; Jonathan Evans; Colin Freeman; Emma Gray; John Hardy; Gavin Hudson; Sarah Hunt; Janusz Jankowski; Cordelia Langford; Andrew J Lees; Hugh S Markus; Christopher G Mathew; Mark I McCarthy; Karen E Morrison; Colin N A Palmer; Justin P Pearson; Leena Peltonen; Matti Pirinen; Robert Plomin; Simon Potter; Anna Rautanen; Stephen J Sawcer; Zhan Su; Richard C Trembath; Ananth C Viswanathan; Nigel W Williams; Huw R Morris; Peter Donnelly; Nicholas W Wood Journal: Hum Mol Genet Date: 2010-11-02 Impact factor: 6.150
Authors: Taye H Hamza; Cyrus P Zabetian; Albert Tenesa; Alain Laederach; Jennifer Montimurro; Dora Yearout; Denise M Kay; Kimberly F Doheny; Justin Paschall; Elizabeth Pugh; Victoria I Kusel; Randall Collura; John Roberts; Alida Griffith; Ali Samii; William K Scott; John Nutt; Stewart A Factor; Haydeh Payami Journal: Nat Genet Date: 2010-08-15 Impact factor: 38.330
Authors: Javier Simón-Sánchez; Claudia Schulte; Jose M Bras; Manu Sharma; J Raphael Gibbs; Daniela Berg; Coro Paisan-Ruiz; Peter Lichtner; Sonja W Scholz; Dena G Hernandez; Rejko Krüger; Monica Federoff; Christine Klein; Alison Goate; Joel Perlmutter; Michael Bonin; Michael A Nalls; Thomas Illig; Christian Gieger; Henry Houlden; Michael Steffens; Michael S Okun; Brad A Racette; Mark R Cookson; Kelly D Foote; Hubert H Fernandez; Bryan J Traynor; Stefan Schreiber; Sampath Arepalli; Ryan Zonozi; Katrina Gwinn; Marcel van der Brug; Grisel Lopez; Stephen J Chanock; Arthur Schatzkin; Yikyung Park; Albert Hollenbeck; Jianjun Gao; Xuemei Huang; Nick W Wood; Delia Lorenz; Günther Deuschl; Honglei Chen; Olaf Riess; John A Hardy; Andrew B Singleton; Thomas Gasser Journal: Nat Genet Date: 2009-11-15 Impact factor: 38.330
Authors: Michael S Cunnington; Chris Kay; Peter J Avery; Bongani M Mayosi; Mauro Santibanez Koref; Bernard Keavney Journal: BMC Med Genet Date: 2009-12-14 Impact factor: 2.103
Authors: Matthew R Lincoln; Sreeram V Ramagopalan; Michael J Chao; Blanca M Herrera; Gabriele C Deluca; Sarah-Michelle Orton; David A Dyment; A Dessa Sadovnick; George C Ebers Journal: Proc Natl Acad Sci U S A Date: 2009-04-20 Impact factor: 11.205
Authors: Jacob O Kitzman; Matthew W Snyder; Mario Ventura; Alexandra P Lewis; Ruolan Qiu; Lavone E Simmons; Hilary S Gammill; Craig E Rubens; Donna A Santillan; Jeffrey C Murray; Holly K Tabor; Michael J Bamshad; Evan E Eichler; Jay Shendure Journal: Sci Transl Med Date: 2012-06-06 Impact factor: 17.956
Authors: George K Tofaris; Hyoung Tae Kim; Raphael Hourez; Jin-Woo Jung; Kwang Pyo Kim; Alfred L Goldberg Journal: Proc Natl Acad Sci U S A Date: 2011-09-27 Impact factor: 11.205